MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation

NCT04967287 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
124
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Dopavision GmbH